Global Anti-obesity Drugs Market Research Report 2024(Status and Outlook)
Report Overview:
Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain dieting and physical exercise.
The Global Anti-obesity Drugs Market Size was estimated at USD 2175.77 million in 2023 and is projected to reach USD 5581.20 million by 2029, exhibiting a CAGR of 17.00% during the forecast period.
This report provides a deep insight into the global Anti-obesity Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-obesity Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-obesity Drugs market in any manner.
Global Anti-obesity Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Novo Nordisk
Pfizer
Arena Pharmaceuticals
Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Amylin
Alizyme
Boehringer Ingelheim
Eisai
Market Segmentation (by Type)
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Market Segmentation (by Application)
Kids
Adults
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-obesity Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain dieting and physical exercise.
The Global Anti-obesity Drugs Market Size was estimated at USD 2175.77 million in 2023 and is projected to reach USD 5581.20 million by 2029, exhibiting a CAGR of 17.00% during the forecast period.
This report provides a deep insight into the global Anti-obesity Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-obesity Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-obesity Drugs market in any manner.
Global Anti-obesity Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Novo Nordisk
Pfizer
Arena Pharmaceuticals
Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Amylin
Alizyme
Boehringer Ingelheim
Eisai
Market Segmentation (by Type)
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Market Segmentation (by Application)
Kids
Adults
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Anti-obesity Drugs Market
- Overview of the regional outlook of the Anti-obesity Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-obesity Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Anti-obesity Drugs
1.2 Key Market Segments
1.2.1 Anti-obesity Drugs Segment by Type
1.2.2 Anti-obesity Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-OBESITY DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-obesity Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anti-obesity Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-OBESITY DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Anti-obesity Drugs Sales by Manufacturers (2019-2024)
3.2 Global Anti-obesity Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-obesity Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-obesity Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-obesity Drugs Sales Sites, Area Served, Product Type
3.6 Anti-obesity Drugs Market Competitive Situation and Trends
3.6.1 Anti-obesity Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-obesity Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-OBESITY DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Anti-obesity Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-OBESITY DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTI-OBESITY DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-obesity Drugs Sales Market Share by Type (2019-2024)
6.3 Global Anti-obesity Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Anti-obesity Drugs Price by Type (2019-2024)
7 ANTI-OBESITY DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-obesity Drugs Market Sales by Application (2019-2024)
7.3 Global Anti-obesity Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-obesity Drugs Sales Growth Rate by Application (2019-2024)
8 ANTI-OBESITY DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Anti-obesity Drugs Sales by Region
8.1.1 Global Anti-obesity Drugs Sales by Region
8.1.2 Global Anti-obesity Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-obesity Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-obesity Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-obesity Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-obesity Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-obesity Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck Anti-obesity Drugs Basic Information
9.1.2 Merck Anti-obesity Drugs Product Overview
9.1.3 Merck Anti-obesity Drugs Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Anti-obesity Drugs SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Novo Nordisk
9.2.1 Novo Nordisk Anti-obesity Drugs Basic Information
9.2.2 Novo Nordisk Anti-obesity Drugs Product Overview
9.2.3 Novo Nordisk Anti-obesity Drugs Product Market Performance
9.2.4 Novo Nordisk Business Overview
9.2.5 Novo Nordisk Anti-obesity Drugs SWOT Analysis
9.2.6 Novo Nordisk Recent Developments
9.3 Pfizer
9.3.1 Pfizer Anti-obesity Drugs Basic Information
9.3.2 Pfizer Anti-obesity Drugs Product Overview
9.3.3 Pfizer Anti-obesity Drugs Product Market Performance
9.3.4 Pfizer Anti-obesity Drugs SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Arena Pharmaceuticals
9.4.1 Arena Pharmaceuticals Anti-obesity Drugs Basic Information
9.4.2 Arena Pharmaceuticals Anti-obesity Drugs Product Overview
9.4.3 Arena Pharmaceuticals Anti-obesity Drugs Product Market Performance
9.4.4 Arena Pharmaceuticals Business Overview
9.4.5 Arena Pharmaceuticals Recent Developments
9.5 Roche
9.5.1 Roche Anti-obesity Drugs Basic Information
9.5.2 Roche Anti-obesity Drugs Product Overview
9.5.3 Roche Anti-obesity Drugs Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Anti-obesity Drugs Basic Information
9.6.2 GlaxoSmithKline Anti-obesity Drugs Product Overview
9.6.3 GlaxoSmithKline Anti-obesity Drugs Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
9.7 Orexigen Therapeutics
9.7.1 Orexigen Therapeutics Anti-obesity Drugs Basic Information
9.7.2 Orexigen Therapeutics Anti-obesity Drugs Product Overview
9.7.3 Orexigen Therapeutics Anti-obesity Drugs Product Market Performance
9.7.4 Orexigen Therapeutics Business Overview
9.7.5 Orexigen Therapeutics Recent Developments
9.8 Vivus
9.8.1 Vivus Anti-obesity Drugs Basic Information
9.8.2 Vivus Anti-obesity Drugs Product Overview
9.8.3 Vivus Anti-obesity Drugs Product Market Performance
9.8.4 Vivus Business Overview
9.8.5 Vivus Recent Developments
9.9 Amylin
9.9.1 Amylin Anti-obesity Drugs Basic Information
9.9.2 Amylin Anti-obesity Drugs Product Overview
9.9.3 Amylin Anti-obesity Drugs Product Market Performance
9.9.4 Amylin Business Overview
9.9.5 Amylin Recent Developments
9.10 Alizyme
9.10.1 Alizyme Anti-obesity Drugs Basic Information
9.10.2 Alizyme Anti-obesity Drugs Product Overview
9.10.3 Alizyme Anti-obesity Drugs Product Market Performance
9.10.4 Alizyme Business Overview
9.10.5 Alizyme Recent Developments
9.11 Boehringer Ingelheim
9.11.1 Boehringer Ingelheim Anti-obesity Drugs Basic Information
9.11.2 Boehringer Ingelheim Anti-obesity Drugs Product Overview
9.11.3 Boehringer Ingelheim Anti-obesity Drugs Product Market Performance
9.11.4 Boehringer Ingelheim Business Overview
9.11.5 Boehringer Ingelheim Recent Developments
9.12 Eisai
9.12.1 Eisai Anti-obesity Drugs Basic Information
9.12.2 Eisai Anti-obesity Drugs Product Overview
9.12.3 Eisai Anti-obesity Drugs Product Market Performance
9.12.4 Eisai Business Overview
9.12.5 Eisai Recent Developments
10 ANTI-OBESITY DRUGS MARKET FORECAST BY REGION
10.1 Global Anti-obesity Drugs Market Size Forecast
10.2 Global Anti-obesity Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anti-obesity Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Anti-obesity Drugs Market Size Forecast by Region
10.2.4 South America Anti-obesity Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anti-obesity Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Anti-obesity Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anti-obesity Drugs by Type (2025-2030)
11.1.2 Global Anti-obesity Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anti-obesity Drugs by Type (2025-2030)
11.2 Global Anti-obesity Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Anti-obesity Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Anti-obesity Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Anti-obesity Drugs
1.2 Key Market Segments
1.2.1 Anti-obesity Drugs Segment by Type
1.2.2 Anti-obesity Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-OBESITY DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-obesity Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anti-obesity Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-OBESITY DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Anti-obesity Drugs Sales by Manufacturers (2019-2024)
3.2 Global Anti-obesity Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-obesity Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-obesity Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-obesity Drugs Sales Sites, Area Served, Product Type
3.6 Anti-obesity Drugs Market Competitive Situation and Trends
3.6.1 Anti-obesity Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-obesity Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-OBESITY DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Anti-obesity Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-OBESITY DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTI-OBESITY DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-obesity Drugs Sales Market Share by Type (2019-2024)
6.3 Global Anti-obesity Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Anti-obesity Drugs Price by Type (2019-2024)
7 ANTI-OBESITY DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-obesity Drugs Market Sales by Application (2019-2024)
7.3 Global Anti-obesity Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-obesity Drugs Sales Growth Rate by Application (2019-2024)
8 ANTI-OBESITY DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Anti-obesity Drugs Sales by Region
8.1.1 Global Anti-obesity Drugs Sales by Region
8.1.2 Global Anti-obesity Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-obesity Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-obesity Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-obesity Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-obesity Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-obesity Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck Anti-obesity Drugs Basic Information
9.1.2 Merck Anti-obesity Drugs Product Overview
9.1.3 Merck Anti-obesity Drugs Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Anti-obesity Drugs SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Novo Nordisk
9.2.1 Novo Nordisk Anti-obesity Drugs Basic Information
9.2.2 Novo Nordisk Anti-obesity Drugs Product Overview
9.2.3 Novo Nordisk Anti-obesity Drugs Product Market Performance
9.2.4 Novo Nordisk Business Overview
9.2.5 Novo Nordisk Anti-obesity Drugs SWOT Analysis
9.2.6 Novo Nordisk Recent Developments
9.3 Pfizer
9.3.1 Pfizer Anti-obesity Drugs Basic Information
9.3.2 Pfizer Anti-obesity Drugs Product Overview
9.3.3 Pfizer Anti-obesity Drugs Product Market Performance
9.3.4 Pfizer Anti-obesity Drugs SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Arena Pharmaceuticals
9.4.1 Arena Pharmaceuticals Anti-obesity Drugs Basic Information
9.4.2 Arena Pharmaceuticals Anti-obesity Drugs Product Overview
9.4.3 Arena Pharmaceuticals Anti-obesity Drugs Product Market Performance
9.4.4 Arena Pharmaceuticals Business Overview
9.4.5 Arena Pharmaceuticals Recent Developments
9.5 Roche
9.5.1 Roche Anti-obesity Drugs Basic Information
9.5.2 Roche Anti-obesity Drugs Product Overview
9.5.3 Roche Anti-obesity Drugs Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Anti-obesity Drugs Basic Information
9.6.2 GlaxoSmithKline Anti-obesity Drugs Product Overview
9.6.3 GlaxoSmithKline Anti-obesity Drugs Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
9.7 Orexigen Therapeutics
9.7.1 Orexigen Therapeutics Anti-obesity Drugs Basic Information
9.7.2 Orexigen Therapeutics Anti-obesity Drugs Product Overview
9.7.3 Orexigen Therapeutics Anti-obesity Drugs Product Market Performance
9.7.4 Orexigen Therapeutics Business Overview
9.7.5 Orexigen Therapeutics Recent Developments
9.8 Vivus
9.8.1 Vivus Anti-obesity Drugs Basic Information
9.8.2 Vivus Anti-obesity Drugs Product Overview
9.8.3 Vivus Anti-obesity Drugs Product Market Performance
9.8.4 Vivus Business Overview
9.8.5 Vivus Recent Developments
9.9 Amylin
9.9.1 Amylin Anti-obesity Drugs Basic Information
9.9.2 Amylin Anti-obesity Drugs Product Overview
9.9.3 Amylin Anti-obesity Drugs Product Market Performance
9.9.4 Amylin Business Overview
9.9.5 Amylin Recent Developments
9.10 Alizyme
9.10.1 Alizyme Anti-obesity Drugs Basic Information
9.10.2 Alizyme Anti-obesity Drugs Product Overview
9.10.3 Alizyme Anti-obesity Drugs Product Market Performance
9.10.4 Alizyme Business Overview
9.10.5 Alizyme Recent Developments
9.11 Boehringer Ingelheim
9.11.1 Boehringer Ingelheim Anti-obesity Drugs Basic Information
9.11.2 Boehringer Ingelheim Anti-obesity Drugs Product Overview
9.11.3 Boehringer Ingelheim Anti-obesity Drugs Product Market Performance
9.11.4 Boehringer Ingelheim Business Overview
9.11.5 Boehringer Ingelheim Recent Developments
9.12 Eisai
9.12.1 Eisai Anti-obesity Drugs Basic Information
9.12.2 Eisai Anti-obesity Drugs Product Overview
9.12.3 Eisai Anti-obesity Drugs Product Market Performance
9.12.4 Eisai Business Overview
9.12.5 Eisai Recent Developments
10 ANTI-OBESITY DRUGS MARKET FORECAST BY REGION
10.1 Global Anti-obesity Drugs Market Size Forecast
10.2 Global Anti-obesity Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anti-obesity Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Anti-obesity Drugs Market Size Forecast by Region
10.2.4 South America Anti-obesity Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anti-obesity Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Anti-obesity Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anti-obesity Drugs by Type (2025-2030)
11.1.2 Global Anti-obesity Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anti-obesity Drugs by Type (2025-2030)
11.2 Global Anti-obesity Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Anti-obesity Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Anti-obesity Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-obesity Drugs Market Size Comparison by Region (M USD)
Table 5. Global Anti-obesity Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Anti-obesity Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-obesity Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-obesity Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-obesity Drugs as of 2022)
Table 10. Global Market Anti-obesity Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-obesity Drugs Sales Sites and Area Served
Table 12. Manufacturers Anti-obesity Drugs Product Type
Table 13. Global Anti-obesity Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-obesity Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-obesity Drugs Market Challenges
Table 22. Global Anti-obesity Drugs Sales by Type (Kilotons)
Table 23. Global Anti-obesity Drugs Market Size by Type (M USD)
Table 24. Global Anti-obesity Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Anti-obesity Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Anti-obesity Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-obesity Drugs Market Size Share by Type (2019-2024)
Table 28. Global Anti-obesity Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Anti-obesity Drugs Sales (Kilotons) by Application
Table 30. Global Anti-obesity Drugs Market Size by Application
Table 31. Global Anti-obesity Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Anti-obesity Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Anti-obesity Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-obesity Drugs Market Share by Application (2019-2024)
Table 35. Global Anti-obesity Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-obesity Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Anti-obesity Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Anti-obesity Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Anti-obesity Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Anti-obesity Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Anti-obesity Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Anti-obesity Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck Anti-obesity Drugs Basic Information
Table 44. Merck Anti-obesity Drugs Product Overview
Table 45. Merck Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Anti-obesity Drugs SWOT Analysis
Table 48. Merck Recent Developments
Table 49. Novo Nordisk Anti-obesity Drugs Basic Information
Table 50. Novo Nordisk Anti-obesity Drugs Product Overview
Table 51. Novo Nordisk Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novo Nordisk Business Overview
Table 53. Novo Nordisk Anti-obesity Drugs SWOT Analysis
Table 54. Novo Nordisk Recent Developments
Table 55. Pfizer Anti-obesity Drugs Basic Information
Table 56. Pfizer Anti-obesity Drugs Product Overview
Table 57. Pfizer Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pfizer Anti-obesity Drugs SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Arena Pharmaceuticals Anti-obesity Drugs Basic Information
Table 62. Arena Pharmaceuticals Anti-obesity Drugs Product Overview
Table 63. Arena Pharmaceuticals Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Arena Pharmaceuticals Business Overview
Table 65. Arena Pharmaceuticals Recent Developments
Table 66. Roche Anti-obesity Drugs Basic Information
Table 67. Roche Anti-obesity Drugs Product Overview
Table 68. Roche Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Roche Business Overview
Table 70. Roche Recent Developments
Table 71. GlaxoSmithKline Anti-obesity Drugs Basic Information
Table 72. GlaxoSmithKline Anti-obesity Drugs Product Overview
Table 73. GlaxoSmithKline Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Recent Developments
Table 76. Orexigen Therapeutics Anti-obesity Drugs Basic Information
Table 77. Orexigen Therapeutics Anti-obesity Drugs Product Overview
Table 78. Orexigen Therapeutics Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Orexigen Therapeutics Business Overview
Table 80. Orexigen Therapeutics Recent Developments
Table 81. Vivus Anti-obesity Drugs Basic Information
Table 82. Vivus Anti-obesity Drugs Product Overview
Table 83. Vivus Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Vivus Business Overview
Table 85. Vivus Recent Developments
Table 86. Amylin Anti-obesity Drugs Basic Information
Table 87. Amylin Anti-obesity Drugs Product Overview
Table 88. Amylin Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Amylin Business Overview
Table 90. Amylin Recent Developments
Table 91. Alizyme Anti-obesity Drugs Basic Information
Table 92. Alizyme Anti-obesity Drugs Product Overview
Table 93. Alizyme Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Alizyme Business Overview
Table 95. Alizyme Recent Developments
Table 96. Boehringer Ingelheim Anti-obesity Drugs Basic Information
Table 97. Boehringer Ingelheim Anti-obesity Drugs Product Overview
Table 98. Boehringer Ingelheim Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Boehringer Ingelheim Business Overview
Table 100. Boehringer Ingelheim Recent Developments
Table 101. Eisai Anti-obesity Drugs Basic Information
Table 102. Eisai Anti-obesity Drugs Product Overview
Table 103. Eisai Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Eisai Business Overview
Table 105. Eisai Recent Developments
Table 106. Global Anti-obesity Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Anti-obesity Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Anti-obesity Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Anti-obesity Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Anti-obesity Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Anti-obesity Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Anti-obesity Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Anti-obesity Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Anti-obesity Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Anti-obesity Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Anti-obesity Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Anti-obesity Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Anti-obesity Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Anti-obesity Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Anti-obesity Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Anti-obesity Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Anti-obesity Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-obesity Drugs Market Size Comparison by Region (M USD)
Table 5. Global Anti-obesity Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Anti-obesity Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-obesity Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-obesity Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-obesity Drugs as of 2022)
Table 10. Global Market Anti-obesity Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-obesity Drugs Sales Sites and Area Served
Table 12. Manufacturers Anti-obesity Drugs Product Type
Table 13. Global Anti-obesity Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-obesity Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-obesity Drugs Market Challenges
Table 22. Global Anti-obesity Drugs Sales by Type (Kilotons)
Table 23. Global Anti-obesity Drugs Market Size by Type (M USD)
Table 24. Global Anti-obesity Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Anti-obesity Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Anti-obesity Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-obesity Drugs Market Size Share by Type (2019-2024)
Table 28. Global Anti-obesity Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Anti-obesity Drugs Sales (Kilotons) by Application
Table 30. Global Anti-obesity Drugs Market Size by Application
Table 31. Global Anti-obesity Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Anti-obesity Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Anti-obesity Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-obesity Drugs Market Share by Application (2019-2024)
Table 35. Global Anti-obesity Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-obesity Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Anti-obesity Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Anti-obesity Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Anti-obesity Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Anti-obesity Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Anti-obesity Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Anti-obesity Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck Anti-obesity Drugs Basic Information
Table 44. Merck Anti-obesity Drugs Product Overview
Table 45. Merck Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Anti-obesity Drugs SWOT Analysis
Table 48. Merck Recent Developments
Table 49. Novo Nordisk Anti-obesity Drugs Basic Information
Table 50. Novo Nordisk Anti-obesity Drugs Product Overview
Table 51. Novo Nordisk Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novo Nordisk Business Overview
Table 53. Novo Nordisk Anti-obesity Drugs SWOT Analysis
Table 54. Novo Nordisk Recent Developments
Table 55. Pfizer Anti-obesity Drugs Basic Information
Table 56. Pfizer Anti-obesity Drugs Product Overview
Table 57. Pfizer Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pfizer Anti-obesity Drugs SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Arena Pharmaceuticals Anti-obesity Drugs Basic Information
Table 62. Arena Pharmaceuticals Anti-obesity Drugs Product Overview
Table 63. Arena Pharmaceuticals Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Arena Pharmaceuticals Business Overview
Table 65. Arena Pharmaceuticals Recent Developments
Table 66. Roche Anti-obesity Drugs Basic Information
Table 67. Roche Anti-obesity Drugs Product Overview
Table 68. Roche Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Roche Business Overview
Table 70. Roche Recent Developments
Table 71. GlaxoSmithKline Anti-obesity Drugs Basic Information
Table 72. GlaxoSmithKline Anti-obesity Drugs Product Overview
Table 73. GlaxoSmithKline Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Recent Developments
Table 76. Orexigen Therapeutics Anti-obesity Drugs Basic Information
Table 77. Orexigen Therapeutics Anti-obesity Drugs Product Overview
Table 78. Orexigen Therapeutics Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Orexigen Therapeutics Business Overview
Table 80. Orexigen Therapeutics Recent Developments
Table 81. Vivus Anti-obesity Drugs Basic Information
Table 82. Vivus Anti-obesity Drugs Product Overview
Table 83. Vivus Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Vivus Business Overview
Table 85. Vivus Recent Developments
Table 86. Amylin Anti-obesity Drugs Basic Information
Table 87. Amylin Anti-obesity Drugs Product Overview
Table 88. Amylin Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Amylin Business Overview
Table 90. Amylin Recent Developments
Table 91. Alizyme Anti-obesity Drugs Basic Information
Table 92. Alizyme Anti-obesity Drugs Product Overview
Table 93. Alizyme Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Alizyme Business Overview
Table 95. Alizyme Recent Developments
Table 96. Boehringer Ingelheim Anti-obesity Drugs Basic Information
Table 97. Boehringer Ingelheim Anti-obesity Drugs Product Overview
Table 98. Boehringer Ingelheim Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Boehringer Ingelheim Business Overview
Table 100. Boehringer Ingelheim Recent Developments
Table 101. Eisai Anti-obesity Drugs Basic Information
Table 102. Eisai Anti-obesity Drugs Product Overview
Table 103. Eisai Anti-obesity Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Eisai Business Overview
Table 105. Eisai Recent Developments
Table 106. Global Anti-obesity Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Anti-obesity Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Anti-obesity Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Anti-obesity Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Anti-obesity Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Anti-obesity Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Anti-obesity Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Anti-obesity Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Anti-obesity Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Anti-obesity Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Anti-obesity Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Anti-obesity Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Anti-obesity Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Anti-obesity Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Anti-obesity Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Anti-obesity Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Anti-obesity Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Anti-obesity Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-obesity Drugs Market Size (M USD), 2019-2030
Figure 5. Global Anti-obesity Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Anti-obesity Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-obesity Drugs Market Size by Country (M USD)
Figure 11. Anti-obesity Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Anti-obesity Drugs Revenue Share by Manufacturers in 2023
Figure 13. Anti-obesity Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-obesity Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-obesity Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-obesity Drugs Market Share by Type
Figure 18. Sales Market Share of Anti-obesity Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Anti-obesity Drugs by Type in 2023
Figure 20. Market Size Share of Anti-obesity Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-obesity Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-obesity Drugs Market Share by Application
Figure 24. Global Anti-obesity Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-obesity Drugs Sales Market Share by Application in 2023
Figure 26. Global Anti-obesity Drugs Market Share by Application (2019-2024)
Figure 27. Global Anti-obesity Drugs Market Share by Application in 2023
Figure 28. Global Anti-obesity Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-obesity Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Anti-obesity Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Anti-obesity Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-obesity Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Anti-obesity Drugs Sales Market Share by Country in 2023
Figure 37. Germany Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Anti-obesity Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Anti-obesity Drugs Sales Market Share by Region in 2023
Figure 44. China Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Anti-obesity Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Anti-obesity Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Anti-obesity Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Anti-obesity Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Anti-obesity Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Anti-obesity Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Anti-obesity Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Anti-obesity Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Anti-obesity Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Anti-obesity Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Anti-obesity Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-obesity Drugs Market Size (M USD), 2019-2030
Figure 5. Global Anti-obesity Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Anti-obesity Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-obesity Drugs Market Size by Country (M USD)
Figure 11. Anti-obesity Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Anti-obesity Drugs Revenue Share by Manufacturers in 2023
Figure 13. Anti-obesity Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-obesity Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-obesity Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-obesity Drugs Market Share by Type
Figure 18. Sales Market Share of Anti-obesity Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Anti-obesity Drugs by Type in 2023
Figure 20. Market Size Share of Anti-obesity Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-obesity Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-obesity Drugs Market Share by Application
Figure 24. Global Anti-obesity Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-obesity Drugs Sales Market Share by Application in 2023
Figure 26. Global Anti-obesity Drugs Market Share by Application (2019-2024)
Figure 27. Global Anti-obesity Drugs Market Share by Application in 2023
Figure 28. Global Anti-obesity Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-obesity Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Anti-obesity Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Anti-obesity Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-obesity Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Anti-obesity Drugs Sales Market Share by Country in 2023
Figure 37. Germany Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Anti-obesity Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Anti-obesity Drugs Sales Market Share by Region in 2023
Figure 44. China Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Anti-obesity Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Anti-obesity Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Anti-obesity Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Anti-obesity Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Anti-obesity Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Anti-obesity Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Anti-obesity Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Anti-obesity Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Anti-obesity Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Anti-obesity Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Anti-obesity Drugs Market Share Forecast by Application (2025-2030)
